Khalid Mezzi
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
-
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Hematology 18
- Multiple Myeloma Research and Treatments 18
- Oncology 1
- Colorectal Cancer Treatments and Studies 1
- Co-authors
- Emma Scott (2 shared papers)Ajai Chari (3 shared papers)Saad Z. Usmani (2 shared papers)Nina D. Shah (1 shared paper)David Samuel DiCapua Siegel (6 shared papers)Noopur S. Raje (2 shared papers)Adam D. Cohen (2 shared papers)Madhav V. Dhodapkar (1 shared paper)
- Journals
- Blood (6 papers)Leukemia (2 papers)BMC Cancer (1 paper)The Oncologist (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesFranceSpain
In The Last Decade
Khalid Mezzi
21 papers receiving 900 citations
Khalid Mezzi's Hit Papers
Peers
Comparison fields: 5 of 56
- Hematology 564
- Oncology 154
- Immunology 40
- Molecular Biology 118
- Radiology, Nuclear Medicine and Imaging 32
Countries citing papers authored by Khalid Mezzi
This map shows the geographic impact of Khalid Mezzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalid Mezzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalid Mezzi more than expected).
Fields of papers citing papers by Khalid Mezzi
This network shows the impact of papers produced by Khalid Mezzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalid Mezzi. The network helps show where Khalid Mezzi may publish in the future.
Co-authors
The 25 scholars most cited alongside Khalid Mezzi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches Hit paper breakdown → | 2020 | 372 |
| 2 | 2020 | 174 | |
| 3 | 2019 | 96 | |
| 4 | 2019 | 46 | |
| 5 | 2018 | 34 | |
| 6 | 2021 | 32 | |
| 7 | 2020 | 29 | |
| 8 | 2016 | 25 | |
| 9 | 2013 | 22 | |
| 10 | 2017 | 18 | |
| 11 | 2019 | 17 | |
| 12 | 2024 | 14 | |
| 13 | 2020 | 13 | |
| 14 | 2016 | 7 | |
| 15 | 2024 | 7 | |
| 16 | 2017 | 4 | |
| 17 | 2017 | 3 | |
| 18 | 2017 | 2 | |
| 19 | 2016 | 1 | |
| 20 | 2017 | 1 |
About Khalid Mezzi
Khalid Mezzi is a scholar working on Hematology, Oncology, Public Health, Environmental and Occupational Health, Molecular Biology and Nuclear Energy and Engineering, having authored 21 papers that have together received 918 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (18 papers), Colorectal Cancer Treatments and Studies (1 paper), Cell death mechanisms and regulation (1 paper) and Acute Lymphoblastic Leukemia research (1 paper). The work is most often cited by research in Hematology (564 citations), Oncology (154 citations), Immunology (40 citations), Molecular Biology (118 citations) and Radiology, Nuclear Medicine and Imaging (32 citations). Khalid Mezzi has collaborated with scholars based in United States, France and Spain. Frequent co-authors include Emma Scott, Ajai Chari, Saad Z. Usmani, Nina D. Shah, David Samuel DiCapua Siegel, Noopur S. Raje, Adam D. Cohen, Madhav V. Dhodapkar, Jessica A. Fowler and Aaron Seth Rosenberg. Their work appears in journals such as Blood, Leukemia, BMC Cancer, The Oncologist and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.